MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Medivation Company Profile (NASDAQ:MDVN)

Consensus Ratings for Medivation (NASDAQ:MDVN) (?)
Ratings Breakdown: 7 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.59)
Consensus Price Target: $81.00 (187.54% upside)

Current Analysts' Coverage Summary for Medivation (NASDAQ:MDVN)
Show:
DateFirmActionRatingPrice TargetActions
2/6/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Maxim GroupReiterated RatingBuy$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/1/2016WedbushLower Price TargetOutperform$59.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperform$83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Canaccord GenuityDowngradeBuy -> Hold$90.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Brean CapitalLower Price TargetBuy$71.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2015RBC CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015BarclaysLower Price TargetOverweight$75.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2015Jefferies GroupReiterated RatingHold$59.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015JMP SecuritiesLower Price TargetMarket Outperform$152.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2015Cowen and CompanyUpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015NomuraInitiated CoverageBuy$140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2015Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015BTIG ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2015JPMorgan Chase & Co.Boost Price TargetOverweight$130.00 -> $148.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2014Goldman SachsDowngradeBuy -> Neutral$90.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2014Chardan CapitalBoost Price TargetBuy$100.00 -> $122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Sanford C. BernsteinUpgradeMarket Perform -> Outperform$118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingOutperform$104.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha